Navigenics Agrees Not to Market Genetic Testing Services Directly to NY Residents
January 20, 2010
Navigenics Agrees Not to Market Genetic Testing Services Directly to NY Residents
In order to operate in New York, "Navigenics agreed to make certain concessions … by modifying the DTC portion of their business," a regulatory official from the NY Department of Health's Wardsworth Center said this week.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA's Gutierrez Provides Additional Clarity Regarding Oversight of DTC Genomics Firms
May 19, 2010 / Pharmacogenomics Reporter - Privacy Groups Challenge Calif. Bill Pushing Regulatory Exemptions for 'Post-CLIA Bioinformatics Services'
June 24, 2009 / Pharmacogenomics Reporter - ACOG Committee Urges Caution for Genetic Testing to Assess Disease Risk
May 30, 2012 / Pharmacogenomics Reporter - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter - DTC Genomics Firms Say They Want to Comply with FDA Regs but Maintain Direct Access
March 16, 2011 / Pharmacogenomics Reporter